25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification - Wikidata - wikimedia - TriplyDB

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification

http://www.wikidata.org/entity/Q37297677

about

Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans Vitamin D and cardiovascular disease: potential role in health disparities Vitamin D and neurocognitive function Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes Association between serum 25-hydroxyvitamin D and carotid atherosclerotic plaque in Chinese type 2 diabetic patients Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.25-hydroxyvitamin D and parathyroid hormone levels do not predict changes in carotid arterial stiffness: the Multi-Ethnic Study of Atherosclerosis.Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.A rubber transfer gasket to improve the throughput of liquid-liquid extraction in 96-well plates: application to vitamin D testing Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk.25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients.Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients.Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality.Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes The relationship between ultraviolet light exposure and mortality in dialysis patients Is vitamin D deficiency a risk factor for ischemic heart disease in patients with established cardiovascular disease? 10-year follow-up of the Nova Scotia Health Survey.Type 2 diabetes does not attenuate racial differences in coronary calcification.Markers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition study.25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort.Vitamin D deficiency and exogenous vitamin D excess similarly increase diffuse atherosclerotic calcification in apolipoprotein E knockout mice.Role of vitamin D receptor activation in racial disparities in kidney disease outcomes.Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2).A review of the effect of diet on cardiovascular calcification.Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate.Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines.Association between atherosclerosis and osteoporosis, the role of vitamin D Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults.Association of vitamin d receptor-a gene polymorphisms with coronary heart disease in Han Chinese.Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate Vitamin D receptor signaling inhibits atherosclerosis in mice Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).Vitamin D levels and markers of arterial dysfunction in HIV Extraskeletal actions of vitamin D.The quantification of vitamin D receptors in coronary arteries and their association with atherosclerosis.Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy.

P2860

Q24569664-76632DC2-23B3-41A9-A11A-61AF54620E48 Q24621603-4D6F3247-86E7-457C-B54C-835634B91438 Q26991916-A07D2924-6C06-4B5A-9FC9-D2350E476E92 Q28238127-5640156B-948E-428D-BC7E-8A24FF036E57 Q28705618-75E19560-FFA1-4A07-917E-1AE56ACCE6B3 Q30358842-9296254F-93DD-4A8D-A0A6-EC76DE236D0F Q30503036-DB28966A-AD22-49E4-954F-DF9089BE08E8 Q33558799-F9D8B5BD-D8A4-4413-A435-325B68552F4D Q33875012-E24CF37D-75DB-4595-93AC-A0754A47A96A Q33879412-24FF3686-D5B1-456A-8A1D-8017146EF5DD Q33904409-6C8BCE5F-37C0-4155-A1F9-63E971BDDBD5 Q33907260-8C477F58-3B73-430C-ACC4-839B6C5BE775 Q33954224-953501FA-5E2C-40BC-AF3B-B2820BE62BA1 Q34114912-069A6B14-28D5-4A95-81AD-83CEF9506168 Q34123786-CBBA7A96-A6AB-46CB-9B98-3268CDB76A72 Q34263443-8FAD357D-082A-4EB7-A862-CE20EE537B71 Q34455184-333DF880-293D-4F5F-B4D1-A3B428B373A2 Q34507258-84949AAB-D3B1-4C73-83B8-D895228E6D09 Q34812456-C485DD43-3A91-4604-8B2C-261915370B39 Q34842659-4F2671BD-811F-46F6-BBC3-94317FC612AE Q34974224-53B1A35F-2CDE-414A-9FB5-C4913939BD42 Q35053281-915D4CEA-4742-4EB9-82A9-094DB779D987 Q35086343-D526020C-0955-44BA-A9F5-C43745DDFE80 Q35106269-333A3E0A-3DAB-4EA1-8D8E-AD2444026F54 Q35229936-C34B382E-BD05-4B3F-B48F-1F360C3145E6 Q35576334-E6E8925D-D901-426D-B638-37F67503E4CC Q35585755-865457F4-1173-49A9-B0DB-3F2CB374CED8 Q35620168-BBCDBF9A-D179-4840-BAC1-02C1224F3A6B Q35664406-B01BD29B-6632-41E8-B900-F9B998DE2BA7 Q35674067-E7626D6B-B4DA-4D92-B28D-AC44D867BD14 Q35751890-9B680B21-38A9-4D24-B5B8-DE4A6580F051 Q35792121-B2E4FE8B-BEAA-4C13-9807-E46E6EA1B39A Q35983519-4F02B04D-E8E9-4EFC-9F1F-5A1E5169B6AA Q36065512-429B8A99-302C-4028-ABDA-FD54DAF38E04 Q36095111-16CCA9F2-958F-4248-9591-179314F9E8AD Q36102556-1AA4D1E5-3C70-4317-A5A4-8C43EC903AD3 Q36138538-7EA01285-51E2-4BA4-9306-5468908C7696 Q36279173-CC30B954-0539-4B36-81B4-07F45B7F1FE0 Q36291358-DFB9D48A-F5E3-4098-A841-EA5E90D4FCE8 Q36293981-BD3B0C52-CC87-45A2-82B2-4984D652706F

P2860

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification

http://www.wikidata.org/entity/Q37297677

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

25-hydroxyvitamin D levels inv ...... coronary artery calcification

@en

25-hydroxyvitamin D levels inv ...... coronary artery calcification.

@nl

type

label

25-hydroxyvitamin D levels inv ...... coronary artery calcification

@en

25-hydroxyvitamin D levels inv ...... coronary artery calcification.

@nl

prefLabel

25-hydroxyvitamin D levels inv ...... coronary artery calcification

@en

25-hydroxyvitamin D levels inv ...... coronary artery calcification.

@nl

P1433

Q37297677-20550D38-6AF5-4044-935C-D8FA55A7E6F3

P1476

Q37297677-788A70C7-5A27-44E4-93DD-0D1CC218ED90

P2093

Q37297677-24EE6CB2-34B7-4C9E-B286-996CF1C1F327

Q37297677-352A8933-27A6-417E-A3E0-59220CF7309F

Q37297677-4FCA45CF-9EAD-48AB-A7A4-C91893C4C297

Q37297677-CB08C09B-446B-4087-B336-5C6944987A75

P2860

Q37297677-0637E57A-368D-4784-8BF2-24CD5CFDC8AD

Q37297677-06EB99C9-E78E-4EDE-B8A2-0D7FCDFE4DCE

Q37297677-0755557F-4FEE-43C5-BA5E-6392445C304B

Q37297677-07B19F61-13F4-4FA6-9316-5A4F086682B8

Q37297677-0893C5E3-448C-490F-9AB7-FE1DF118CCF2

Q37297677-0A34308E-3EE0-47DB-9551-9B827DD7EAB0

Q37297677-0A3EF1E2-E260-4E92-B48D-7C04E743BEA1

Q37297677-26C47AD9-B8CB-4989-8262-CC47526B670B

Q37297677-3732DEAB-4E45-4B95-A607-B8BC5ABFF7D3

Q37297677-40431CD4-B61A-436D-9FBC-129964242203

P304

Q37297677-0239E4E8-7A48-4608-AE5A-8C98A41323DE

P31

Q37297677-84B2CBC5-F85F-41AC-B4E1-1D19A9D97F32

P356

Q37297677-186877EE-E5F1-46F2-965A-DE681E7E2EE8

P433

Q37297677-B256D35E-0EF1-40EE-B5DB-4DC8D88E59E9

P478

Q37297677-4AC3D3EB-D8E1-4E94-9E0E-B93687A17161

P50

Q37297677-981EB48D-14F3-4A3F-B978-FEA2507099A0

Q37297677-FDFD2852-CDEE-4ABD-9A74-8B3AB6B304BF

P577

Q37297677-BD6DBF77-C434-4A36-94E5-87D86BD9BBC9

P5875

Q37297677-9CE45304-C28F-4649-86EE-91B463B5BFBB

P698

Q37297677-5EDB4A32-6F4E-4D45-9FBB-0E7D8CC9F31F

P932

Q37297677-58832337-D388-4436-896D-AF0104794CBF

P356

P1433

Journal of the American Society of Nephrology

P1476

25-hydroxyvitamin D levels inv ...... coronary artery calcification

@en

P2093

Abigail B Shoben

http://www.w3.org/2001/XMLSchema#string

Erin D Michos

http://www.w3.org/2001/XMLSchema#string

Ian H de Boer

http://www.w3.org/2001/XMLSchema#string

Mark J Sarnak

http://www.w3.org/2001/XMLSchema#string

P2860

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds

25-hydroxyvitamin D levels and the risk of mortality in the general population

Compendium of physical activities: an update of activity codes and MET intensities

Active serum vitamin D levels are inversely correlated with coronary calcification

Standards of medical care in diabetes--2006

Compendium of Physical Activities: an update of activity codes and MET intensities

Evaluation of methods for the measurement of low-density lipoprotein cholesterol.

Multi-Ethnic Study of Atherosclerosis: objectives and design

P304

1805-1812

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2008111157

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

David S Siscovick

Bryan R Kestenbaum

P577

2009-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24428702

http://www.w3.org/2001/XMLSchema#string

P698

19443637

http://www.w3.org/2001/XMLSchema#string

P932

2723983

http://www.w3.org/2001/XMLSchema#string